OSL
Oncosil Medical Ltd
🇦🇺 ASX
🔭 LIFE SCIENCES TOOLS & SERVICES
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-19.02%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in Macquarie, New South Wales. The company went IPO on 2005-08-15. The firm is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The firm has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.
📈 Performance
Price History
-90.93%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in OSL
5
📊 Total Capital Earnings
$983.25
🔃 Average investment frequency
80 weeks
💵 Average investment amount
$573
⏰ Last time a customer invested in OSL
23 days
OSL investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
40%
50k - 100k
40%
Less than 50k
20%
👶 Age of investors
18 - 25
26 - 34
60%
35 - 90
40%
🙋 Legal gender of investors
Female
20%
Male
80%
Pearlers who invest in OSL also invest in...
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
19.73%
📊 Share price
$61.01 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.43%
📊 Share price
$104.33 AUD
🧱 MATERIALS
⛳️ DIVERSIFIED
💸 FINANCIALS
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.09%
📊 Share price
$68.57 AUD
🌏 GLOBAL
⛳️ DIVERSIFIED
LIT
Lithium Australia Ltd. is an Australian based mineral exploration company. The company is headquartered in Kewdale, Western Australia. The company went IPO on 2007-10-30. The firm's Lithium Chemicals segment consists of research and development of a suite of extraction and refining technologies for the recovery of lithium chemicals from various materials, including spodumene, lithium micas and end of life lithium-ion batteries. Its Battery Materials segment provides research and development of advanced, battery materials, including lithium ferro phosphate and lithium manganese ferro phosphate. Its Battery Recycling segment offers research and development of processing technology for mixed-battery recycling, as well as the sale of recovered energy metals. The firm shreds and recycles all types of end-of-life batteries at its Melbourne facilities. Its process involves recovery of energy metals as a mixed metal dust, which is then exported for further refining.
🙌 Performance (5Yr p.a)
-9.41%
📊 Share price
$0.02 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2005-08-15. The firm is focused on the development and commercialization of its lead product candidate, OncoSil localized radiation therapy, for the treatment of pancreatic and distal cholangiocarcinoma. OncoSil is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumors through an endoscopic ultrasound. OncoSil is a single-use brachytherapy device that has received breakthrough device designation in the European Union, the United Kingdom, and the United States for the treatment of unresectable locally advanced pancreatic cancer in combination with chemotherapy. OncoSil comprises phosphorous-32 microparticles suspended in a specially formulated diluent. OncoSil is indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy.
🔭 LIFE SCIENCES TOOLS & SERVICES
Want more shares? Try these...
Orion Minerals Ltd. engages in the business of exploring, evaluating, and developing base metal, gold, and platinum-group element projects. The company is headquartered in Melbourne, Victoria. The company went IPO on 2003-10-31. The firm is engaged in exploration, evaluation and development of base metal, gold, and platinum-group element projects in South Africa (Areachap Belt and Okiep Copper Complex, Northern Cape). Its projects include Prieska Copper-Zinc Mine Project, Okiep Copper Project, Fraser Range Project, Jacomynspan (JMP) Battery Metals Project, Walhalla Project, Stratega Metals Vapour Refining Project, and Areachap Exploration. The Prieska Project is located in the Northern Cape Province of South Africa, approximately 270 kilometers south-west of the regional capital Kimberley. The Okiep Copper Project (OCP) is located in the Northern Cape Province of South Africa, approximately 570 km north of Cape Town and 450 km west of the Company’s flagship Prieska Copper Zinc Project. The JMP Project is located 65 km north of Orion’s flagship Prieska Copper Zinc Mine in South Africa’s Northern Cape.
🙌 Performance (5Yr p.a)
-7.69%
📊 Share price
$0.02 AUD
⛏️ MINING
Orpheus Uranium Ltd. engages in the exploration and development of minerals including gold and copper. The company is headquartered in Adelaide, South Australia. The firm is focused on uranium exploration in the two jurisdictions of Australia that permit uranium mining, South Australia and the Northern Territory. In South Australia there are five key project areas: Frome, Mundaerno, Radium Hill South, Cummins and Marree. In the Northern Territory there are four key project areas: Mount Douglas, Woolner, Alligator Rivers Uranium Field and South Alligator Valley Mineral Field. Its other projects include Higginsville, Kroombit, Aroona, Lumwana West, Kamapanda, Kalaba East, Musangila, and others. The Frome project comprises four exploration licenses covering a combined area of 3,037 square kilometers, located in the Frome Embayment of South Australia. The Mundaerno project comprises one exploration license application, EL 6958, which comprises two blocks in the Southern Curnamona Province of South Australia.
🙌 Performance (5Yr p.a)
144.00%
📊 Share price
$0.04 AUD
⛏️ MINING